Cytecare appoints Dr Mythri Shankar as Senior Consultant – Nuclear Medicine

first_img Share Menopause to become the next game-changer in global femtech solutions industry by 2025 She is a member of international organisations and has 15 years of clinical expertiseCytecare has appointed Dr Mythri Shankar as Senior Consultant, Nuclear Medicine Department. Dr Shankar has trained extensively in Nuclear Medicine from various global institutions such as UCLA, Cedars Sinai, Children’s Hospital of Los Angeles and Harvard Medical School.With over 15 years of clinical expertise, Dr Shankar’s experience has enabled the integration of most appropriate protocol selection while performing sophisticated radioactive injection procedures. She is a member of several international organisations such as the American Society of Nuclear Cardiology and the (US and India), and is also actively involved in academics and several research projects.She is a renowned Women’s Health Activist, an entrepreneur (IIM-B Alumini) and the Founder Trustee of Osteoporosis Foundation, India.Suresh Ramu, CEO and Co-Founder, Cytecare Hospitals, said “We are delighted to have Dr Mythri Shankar on board as our Nuclear Medicine specialist. Targeted therapy with radiopharmaceuticals – radioactive compounds used in nuclear medicine for diagnosis or treatment has demonstrated superior clinical outcomes in trials for cancer treatment. Dr Mythri’s joining the team will definitely be a great impetus for the diagnostic and nuclear medicine-based therapy at Cytecare. With her specialised and research-based approach in nuclear medicine treatment. News By salil sule on July 13, 2017 Read Article Related Posts Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care appcenter_img Cytecare appoints Dr Mythri Shankar as Senior Consultant – Nuclear Medicine Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Phoenix Business Consulting invests in telehealth platform Healpha WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals The missing informal workers in India’s vaccine story MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre”last_img

Leave a Reply

Your email address will not be published. Required fields are marked *